Femasys receives CE Mark and Health Canada approval for FemVue MINI fallopian tube assessment

FEMASYS INC

CE Mark certification obtained for FemVue MINI, enabling sales in European Economic Area.
Health Canada granted product approval for FemVue MINI, opening Canadian market.
FemVue MINI is a compact, eco-friendly version of existing FemVue diagnostic product.
CEO Kathy Lee-Sepsick cites expanded access to advanced women's health diagnostics in Europe and Canada.
Product designed with smaller environmental footprint, supporting company sustainability initiatives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.